TICKERNOMICS Sign up
Last Update: 2024-03-28 02:09:38
Fresenius Medical Care AG & Co. KGaA ( FMS ) https://www.freseniusmedicalcare.com
18.91USD
Sector:
Healthcare
Industry:
Medical Care Facilities
Country:
Germany
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
-5.48%
FMS
SPY
32.74%
-42.36%
FMS
SPY
92.93%
-42.42%
FMS
SPY
224.41%
-24.07%
FMS
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
11184.92
25272.94
0.22
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
19.38
0.54
0.69
20.55
3.24
7.61
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
6.57
24.90
15.81
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.627
3.67
4.55
0.90
Other Earnings and Cash Flow Stats:
Fresenius Medical Care AG & Co. KGaA ( FMS ) Net Income TTM ($MM) is 664.37
Fresenius Medical Care AG & Co. KGaA ( FMS ) Operating Income TTM ($MM) is 1006.83
Fresenius Medical Care AG & Co. KGaA ( FMS ) Owners' Earnings Annual ($MM) is 1782.86
Fresenius Medical Care AG & Co. KGaA ( FMS ) Current Price to Owners' Earnings ratio is 6.22
Fresenius Medical Care AG & Co. KGaA ( FMS ) EBITDA TTM ($MM) is 3019.36
Fresenius Medical Care AG & Co. KGaA ( FMS ) EBITDA Margin is 15.81%
Capital Allocation:
Fresenius Medical Care AG & Co. KGaA ( FMS ) has paid 0.62 dividends per share and bought back -0.33403800000008 million shares in the past 12 months
Fresenius Medical Care AG & Co. KGaA ( FMS ) has reduced its debt by 535.32676755387 million USD in the last 12 months
Capital Structure:
Fresenius Medical Care AG & Co. KGaA ( FMS ) Interest-bearing Debt ($MM) as of last quarter is 15729
Fresenius Medical Care AG & Co. KGaA ( FMS ) Annual Working Capital Investments ($MM) are -108
Fresenius Medical Care AG & Co. KGaA ( FMS ) Book Value ($MM) as of last quarter is 16313
Fresenius Medical Care AG & Co. KGaA ( FMS ) Debt/Capital as of last quarter is 106%
Other Balance Sheet Stats:
Fresenius Medical Care AG & Co. KGaA ( FMS ) has 1641 million in cash on hand as of last quarter
Fresenius Medical Care AG & Co. KGaA ( FMS ) has 6996 million of liabilities due within 12 months, and long term debt 9006 as of last quarter
Fresenius Medical Care AG & Co. KGaA ( FMS ) has 586 common shares outstanding as of last quarter
Fresenius Medical Care AG & Co. KGaA ( FMS ) has 0 million USD of preferred stock value
Academic Scores:
Fresenius Medical Care AG & Co. KGaA ( FMS ) Altman Z-Score is 1.50 as of last quarter
Fresenius Medical Care AG & Co. KGaA ( FMS ) Piotroski Score is 8.00 as of last quarter
Corporate Governance:
Fresenius Medical Care AG & Co. KGaA ( FMS ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of Fresenius Medical Care AG & Co. KGaA ( FMS ) for the amount of $ on
0.00% of Fresenius Medical Care AG & Co. KGaA ( FMS ) is held by insiders, and 8.97% is held by institutions
Fresenius Medical Care AG & Co. KGaA ( FMS ) went public on 1996-09-19
Other Fresenius Medical Care AG & Co. KGaA ( FMS ) financial metrics:
FCF:1632.39
Unlevered Free Cash Flow:2481.28
EPS:0.62
Operating Margin:6.57
Gross Profit Margin:24.90
Div. Payout Ratio%:62.83
Div. Growth YoY%:-12.78
Equity Return%:2.48
Beta:0.90
Buffet's Owners Earnings:1782.86
Price to Owner's Earnings:6.22
About Fresenius Medical Care AG & Co. KGaA ( FMS ) :
Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.